Publikation
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Wissenschaftlicher Artikel/Review - 04.01.2021
Urwyler Pascal, Sendi Parham, Albrich Werner, Stüssi-Helbling Melina, Huber Lars C, Bacci Marcelo R, Camacho-Ortiz Adrián, Sumer Johannes, Thoma Reto, Trendelenburg Marten, Heijnen Ingmar A F M, Moser Stephan, Charitos Panteleimon, Osthoff Michael
Urwyler, Pascal
Charitos, Panteleimon
Moser, Stephan
Heijnen, Ingmar A F M
Trendelenburg, Marten
Thoma, Reto
Sumer, Johannes
Infektiologie | Infektionsprävention | Reisemedizin · Dept. ICamacho-Ortiz, Adrián
Bacci, Marcelo R
Huber, Lars C
Stüssi-Helbling, Melina
Albrich, Werner
Leitende(r) Arzt/ÄrztinInfektiologie | Infektionsprävention | Reisemedizin · Dept. I